Green Tea Extract for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Green Tea Extract for Health & Longevity

Created on 06/23/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A concentrated source of green tea antioxidants offering small but reliable benefits: modest drops in body fat, cholesterol, and blood pressure, plus stronger antioxidant defenses. Blood sugar, cancer, brain, and longevity claims stay unproven. One defining concern is rare but serious liver injury, sharply higher at high doses on an empty stomach. (Full Review)

Protocol

Standard Dose
250–500 mg catechins/day
~200–400 mg EGCG, one or two doses with food
Timing
With food, morning/early afternoon
Food lowers absorption but reduces liver risk; caffeine can disrupt sleep
Split Dosing
Two smaller portions with meals
Preferred over a single large bolus to reduce peak liver burden
Time to effect
Body Composition
8–12 weeks
Reductions in body weight and fat over consistent use
Cholesterol
8–12 weeks
Lower total and LDL cholesterol over consistent use
Blood Pressure
8–12 weeks
Slight drop in systolic and diastolic pressure over consistent use

Benefits

Contraindications
  • Active or prior green-tea-associated liver injury
  • Significant liver disease (e.g., cirrhosis or impaired liver function)
  • Pregnancy and breastfeeding (high-dose extracts)
  • Iron-deficiency anemia (high doses)
  • Bortezomib chemotherapy
    •
Key Interactions
  • Nadolol (beta-blocker)
  • Anticoagulants/antiplatelets (e.g., warfarin)
  • Caffeine-containing OTC products (some pain relievers, cold remedies, stimulant weight-loss aids)
  • Acetaminophen (paracetamol)
  • Iron supplements and iron-rich multivitamins
  • Stimulant supplements (synephrine, additional caffeine, yohimbine)
  • Blood-pressure- or blood-sugar-lowering supplements (berberine, magnesium, beetroot/nitrate)
    •

Risk & Side Effects

  • High: Liver injury (hepatotoxicity); caffeine-related effects
    •
  • Medium: Gastrointestinal upset; reduced iron absorption
    •
  • Low: Blood pressure and cardiovascular effects in sensitive individuals
    •
  • Speculative: Interference with certain medications via reduced absorption or altered metabolism; bone and hormonal effects
    •

Monitoring

Marker Target Why
ALT < 25 U/L (men), < 20 U/L (women) Detects liver cell stress, the key safety concern
AST < 25 U/L Complements ALT in detecting liver injury
LDL cholesterol < 100 mg/dL Tracks the main lipid benefit
Total cholesterol < 200 mg/dL Reflects overall lipid response
Fasting blood glucose 70–90 mg/dL Tracks possible blood-sugar benefit
HbA1c < 5.4% Reflects average blood sugar over ~3 months
Blood pressure < 120/80 mm Hg Tracks the modest blood-pressure benefit
Ferritin 50–150 ng/mL Detects iron depletion from catechin-iron binding

Cadence: Baseline before first dose, then ~4–8 weeks, ~12 weeks, and every 6–12 months during continued use or sooner if symptoms arise

Qualitative Assessment

  • Energy levels and alertness through the day
  • Sleep quality (a sensitive indicator of excess caffeine intake)
  • Digestive comfort, since gastrointestinal upset is a common early side effect
  • Absence of any liver-related warning signs such as unusual fatigue, jaundice, or dark urine
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.